Tag Archives: Elemer Piros

Cantor Fitzgerald Reiterates a Buy Rating on PolarityTE Inc (PTE)

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on PolarityTE Inc (PTE – Research Report), with a price target of $65. The company’s shares opened today at $16.55. Piros wrote: “: We reiterate our

Rigel (RIGL) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros maintained a Buy rating on Rigel (RIGL – Research Report) yesterday and set a price target of $9. The company’s shares closed yesterday at $2.48. Piros wrote: “We believe Rigel is poised to achieved meaningful

Proteostasis Therapeutics Inc (PTI) Gets a Buy Rating from Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros maintained a Buy rating on Proteostasis Therapeutics Inc (PTI – Research Report) yesterday and set a price target of $21. The company’s shares closed yesterday at $4.11. Piros commented: “We reaffirm our OW rating. Proteostasis

Cantor Fitzgerald Thinks Apellis Pharmaceuticals Inc’s Stock is Going to Recover

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Apellis Pharmaceuticals Inc (APLS – Research Report), with a price target of $53. The company’s shares closed yesterday at $14.24, close to its 52-week low

Krystal Biotech Inc (KRYS) Receives a Buy from Cantor Fitzgerald

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Krystal Biotech Inc (KRYS – Research Report), with a price target of $34. The company’s shares closed yesterday at $22.90. Piros said: “We rate Krystal

Cantor Fitzgerald Thinks Abeona Therapeutics’ Stock is Going to Recover

Cantor Fitzgerald analyst Elemer Piros maintained a Buy rating on Abeona Therapeutics (ABEO – Research Report) today and set a price target of $36. The company’s shares opened today at $7.39, close to its 52-week low of $6.94. Piros wrote: